A Legislative Alternative to No Cause Liability in Blood Products Litigation

Recently, tort law commentators have discovered truth in Justice Holmes\u27 maxim that hard cases make bad law. In particular, commentators have criticized cases in which courts have relaxed the traditional rule of causation, permitting plaintiffs to recover damages without connecting their harm to a specific defendant. A notable example has arisen in the context of litigation involving Factor VIII concentrate, a pharmaceutical product used by hemophiliacs to replace the clotting protein missing in their blood